Property and Equipment

12 Months Ended

Dec. 31, 2021

Property Plant And Equipment [Abstract]

Property and Equipment

(6) Property and Equipment

In January 2021, the Company entered into an asset purchase agreement with Catalent Pharma Solutions to sell its Chelsea, Massachusetts manufacturing operations. The Company closed the transaction on February 10, 2021. The Company determined that the criterion to classify the property and equipment being transferred as part of the agreement as held for sale within the Company’s consolidated balance sheet as of December 31, 2020. Accordingly, the property and equipment being transferred as part of the agreement were classified as current assets and current liabilities held for sale at December 31, 2020. See Note 7 to our Consolidated Financial Statements included in this report for a discussion of Assets Held for Sale.

Property and equipment consisted of the following:

(In thousands)	December 31, 2021			December 31, 2020			Estimated useful lives used
Machinery and equipment	$	2,315		$	2,569		2-7 years
Leasehold improvements		15,317			15,317		Lesser of useful life or remaining lease term
Computer equipment		17,973			17,758		1-3 years
Laboratory equipment		1,644			5,343		2-5 years
Furniture and fixtures		2,130			2,129		4-7 years
Construction in progress		—			171
		39,379			43,287
Less accumulated depreciation		(34,997	)		(36,024	)
	$	4,382		$	7,263

Depreciation and amortization expense on property and equipment was $2.9 million and $10.2 million for the years ended December 31, 2021 and 2020, respectively.